Brookline, MA, United States of America

Jason E Fernandez

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jason E Fernandez: Innovator in Antigen Binding Molecules

Introduction

Jason E Fernandez is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of formulations for single domain antigen binding molecules. With a total of 2 patents, his work is paving the way for advancements in pharmaceutical applications.

Latest Patents

Fernandez's latest patents focus on formulations of single domain antigen binding molecules, specifically TNF-binding nanobody molecules. These formulations are designed to interact with target proteins, making them useful as pharmaceutical formulations. The methods of preparing and using these formulations aim to treat TNF-associated disorders, showcasing the potential impact of his inventions in medical treatments.

Career Highlights

Jason E Fernandez is currently associated with Ablynx N.V., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in treating various disorders, highlighting his role as a key player in the industry.

Collaborations

Fernandez collaborates with talented individuals such as Daniel A Dixon and Andrea A Paulson, contributing to a dynamic research environment that fosters innovation and development.

Conclusion

In summary, Jason E Fernandez is a prominent inventor whose work on single domain antigen binding molecules is making strides in the pharmaceutical field. His contributions are essential for the advancement of treatments for TNF-associated disorders, and his ongoing work promises to yield further innovations in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…